Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Preferred Stock Liabilities (2018 - 2019)

TELA Bio has reported Preferred Stock Liabilities over the past 2 years, most recently at $1.6 million for Q3 2019.

  • Quarterly results put Preferred Stock Liabilities at $1.6 million for Q3 2019, down 94.97% from a year ago — trailing twelve months through Sep 2019 was $1.6 million (down 94.97% YoY), and the annual figure for FY2018 was $124.2 million, up 54.4%.
  • Preferred Stock Liabilities for Q3 2019 was $1.6 million at TELA Bio, down from $107.1 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for TELA hit a ceiling of $124.2 million in Q4 2018 and a floor of $1.6 million in Q3 2019.